The promises and challenges of the use of genomics in the prescription of exercise in hypertension

Current Hypertension Reviews

Volumn 6, Issue 1, 2010, Pages 32-43

  Pescatello, Linda S ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Blood pressure; Genetics; Metabolic syndrome; Physical activity; Polymorphisms; Pre hypertension

Indexed keywords

AEROBIC EXERCISE; ANTIHYPERTENSIVE ACTIVITY; BLOOD PRESSURE; CLINICAL TRIAL; DISEASE CONTROL; EXERCISE; GENE; GENOMICS; HUMAN; HYPERTENSION; LABORATORY TEST; MEDICAL INFORMATION; PHYSICAL ACTIVITY; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; THERAPY EFFECT;

EID: 77949689149     PISSN: 15734021     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340210790231735     Document Type: Review

References (55)

1. Lawes CMM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet 2008; 371: 1513-8.
2. American Heart Association. Heart disease and stroke statistics-2008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 11: 85-151.
3. Fields LE, Burt VL, Cutler JA, Hughes J, Roccella EJ, Sorlie P. The burden of adult hypertension in the United States 1999 to 2000: A rising tide. Hypertension 2004; 44: 398-404.
4. Wang Y, Wang QJ. The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines. Arch Intern Med 2004; 64: 2126-34.
5. Chobanian AV, Bakris GL, Black HR, et al. and the National High Blood Pressure Education Program Coordinating Committee. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JNC 7-Complete Version. Hypertension 2003; 42: 1206-52.
6. Staessen JA, Wang JG, Birkenhager WH. Outcome beyond blood pressure control? Eur Heart J 2003; 24: 504-14.
7. Mensah GA, Brown DW. An overview of cardiovascular disease burden in the United States. Health Affairs 2 2007; 6: 38-48.
8. Pescatello LS, Franklin BA, Fagard R, Farquhar W, Kelly GA, Ray CA. American College of Sports Medicine position stand. Exercise and hypertension. Med Sci Sports Exerc 2004; 25: 533-53.
9. Cornelissen VA, Fagard RH. Effects of endurance training on blood pressure, blood pressure-regulating mechanisms, and cardiovascular risk factors. Hypertension 2005; 46: 667-75.
10. Fagard RH. Exercise characteristics and the blood pressure response to dynamic physical training. Med Sci Sports Exerc 2001; 33(Suppl): S484-92.
11. Fagard RH, Cornelissen VA. Effects of exercise on blood pressure control in hypertensive patients. Eur J Cardiovasc Prev Rehabil 2006; 14: 12-17.
12. Kelley GA, Kelley KS. Progressive resistance exercise and resting blood pressure: a meta-analysis of randomized controlled trials. Hypertension 2000; 35: 838-43.
13. Kelley GA, Kelley KS, Tran Z. Aerobic exercise and resting blood pressure: a meta-analytic review of randomized, controlled trials. Prev Cardiol 2001; 4: 73-80.
14. Whelton SP, Chin A, Xin X, He J. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med 2002; 136: 493-503.
15. Pescatello LS, Kulikowich JM. The aftereffects of dynamic exercise on ambulatory blood pressure. Med Sci Sports Exerc 2001; 33: 1855-61.
16. Meredith IT, Jennings GL, Esler MD, et al. Time-course of the antihypertensive and autonomic effects of regular endurance exercise in human subjects. J Hypertens 1990; 8: 859-66.
17. Murray A, Delaney T, Bell C. Rapid onset and offset of circulatory adaptations to exercise training in men. J Hum Hypertens 2006; 20: 193-200.
18. Bouchard C, Rankinen T. Individual differences in response to regular physical activity. Med Sci Sports Exerc 2001; 33: S446-51.
19. Thompson PD, Crouse SF, Goodpasture B, Kelley D, Moyna N, Pescatello LS. The acute versus chronic response to exercise. Med Sci Sports Exerc 2001; 33: S438-45.
20. Roth SM. Perspective on the future use of genomics in exercise prescription. J Appl Physiol 2007; 104: 1243-45 doi:10.1152/japplphysiol. 01000.2007.
21. Roth SM. Perspective on the future use of genomics in exercise prescription. J Appl Physiol 2008; 104: 1252 doi:10.1152/ japplphysiol.01000.2007.
22. Pescatello LS. Commentary on viewpoint: Perspective on the future use of genomics in exercise prescription. J Appl Physiol 2008; 104: 1247.
23. Arnett DK, Baird AE, Barkley RA, et al. Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: A scientific statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation 2007; 115: 2878-2901.
24. Cardon LR, Palmer LJ. Population stratification and spurious allelic association. Lancet 2003; 361, 598-604.
25. Donahue MP, Kraus WE. Genetic association studies; the good, the bad and the ugly. Am Heart J 2007; 154: 610-12.
26. Drysdale CM, McGraw DW, Stack CB, et al. Complex promoter and coding region β2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci 2000; 97: 10483-88.
27. Bray MS, Hagberg JM, Perusse L, et al. The human gene map for performance and health-related fitness phenotypes: The 2006-2007 update. Med Sci Sports Exerc 2009; 41: 34-72.
28. Rankinen T, Gagnon J, Perusse L, et al. AGT M235T and ACE ID polymorphisms and exercise blood pressure in the HERITAGE Family Study. Am J Physiol Heart Circ Physiol 2000; 279: H373-86.
29. Rankinen T, Rice T, Leon AS, et al. G protein β3 polymorphism and hemodynamic and body composition phenotypes in the HERITAGE Family Study. Physiol Genomics 2002; 8: 151-7.
30. Ingelsson E, Larson MG, Vasan RS, et al. Heritability, linkage, and genetic associations of exercise treadmill test responses. Circulation 2007; 115: 2917-24.
31. Rankinen T, Church T, Rice T, et al. Effect of endothelin 1 genotype on blood pressure is dependent on physical activity or physical fitness. Hypertension 2007; 50: 1-6.
32. Shih PB, O'Conor DT. Hereditary determinants of human hypertension strategies in the setting of genetic complexity. Hypertension 2008; 51: 1456-64.
33. Pescatello LS, Guidry MA, Blanchard B, et al. Exercise intensity alters postexercise hypotension. J Hypertens 2004; 22: 1881-88.
34. Pescatello LS, Blanchard BE, Van Heest JL, Maresh CM, Thompson PD. The metabolic syndrome and the immediate antihypertensive effects of aerobic exercise: a randomized control design. BMC Cardiovascular Disorders 2008; 8: 12.
35. Blanchard BE, Tsongalis GJ, Guidry MA, et al. RAAS polymorphisms alter the acute blood pressure response to aerobic exercise among men with hypertension. Eur J Appl Physiol 2006; 97: 26-33.
36. Zemal M. Calcium modulation of hypertension and obesity: mechanisms and implications. J Am Coll Nutr 2001; 20: 428S-35S.
37. Levy BI. Can angiotensin II type 2 receptors have deleterious effects in cardiovascular disease? implications for therapeutic blockade of the rennin-angiotensin system. Circulation 2004; 109: 8-13.
38. Pescatello LS, Turner D, Rodriguez N, et al. Dietary calcium intake and renin angiotensin system polymorphisms alter the blood pressure response to aerobic exercise: a randomized control design. Nutr Metabol 2007; 4: 1.
39. Matsuoka Y, Li X, Bennett V. Adducin: structure, function and regulation. Cell Mol Life Sci 2000; 57:884-95.
40. Bianchi G, Ferrari P, Staessen JA. Adducin polymorphism detection and impact on hypertension and related disorders. Hypertension 2005; 45: 331-40.
41. Sciarrone MT, Stella P, Barlassina C, et al. ACE and α-adducin polymorphism as markers of The individual response to diuretic therapy. Hypertension 2003; 41: 398-403.
42. Pescatello LS, Blanchard BE, Tsongalis GJ, Maresh CM, Thompson PD. Alpha adducin Gly460Trp polymorphism interacts with exercise intensity to alter the blood pressure response following endurance exercise. Clin Sci 2007; 113: 251-58.
43. Whelton SP, Chin S, Xin X , He J. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med 2002; 136: 493-503.
44. sα gene with essential hypertension and response to β-blockade. Hypertension 1999; 34: 8-14.
45. Yasuda K, Matsunaga T, Moritani T, et al. T393C polymorphism of GNAS1 associated with the autonomic nervous system in young, healthy Japanese subjects. Clin Exp Pharmacol Physiol 2004; 3: 597-601.
46. Pescatello LS, Blanchard BE, Tsongalis GJ, Maresh CM, Thompson PD. The GNAS 393 T>C polymorphism and the blood pressure response immediately following aerobic exercise among men with elevated blood pressure. Vasc Dis Prev 2009; 6: 56-64.
47. Gage BF, Eby C, Milligan PE, Banet GA, Duncan JR, McLeod HL. Use of pharmacogenetics and clinical factors to predict the maintenance does of warfarin. Thromb Haemost 2004; 91: 87-94.
48. Pescatello LS, BE Blanchard, GJ Tsongalis, et al. Genetic and clinical determinants of the immediate antihypertensive effects of aerobic exercise. Appl Clin Genetics 2008; 1: 7-17.
49. Hubal MJ, H Gordish-Dressman, PD Thompson, et al. Variability in muscle size and strength gain following unilateral resistance training. Med Sci Sports Exerc 2005; 37: 964-72.
50. Quinn TJ. Twenty-four hour, ambulatory blood pressure responses following exercise: impact of exercise intensity J Hum Hypertens 2000; 14: 547-53.
51. Smelker CL, Foster C, Maher MA, Martinez R, Porcari J. Effect of exercise intensity on postexercise hypotension. J Cardiopulmonary Rehab 2004; 24: 269-273.
52. Wagner PD. Commentary on viewpoint: Perspective on the future use of genomics in exercise prescription. J Appl Physiol 2008; 104: 1246.
53. Brito EC, Franks PW. Commentary on viewpoint: Perspective on the future use of genomics in exercise prescription. J Appl Physiol 2008; 104: 1248.
54. Lightfoot JT. Commentary on viewpoint: Perspective on the future use of genomics in exercise prescription. J Appl Physiol 2008; 104: 1249.
55. Timmons JA. Commentary on viewpoint: Perspective on the future use of genomics in exercise prescription. J Appl Physiol 2008; 104: 1250.